A detailed history of Arrowstreet Capital, Limited Partnership transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 2,092 shares of INSP stock, worth $423,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,092
Holding current value
$423,588
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$125.79 - $216.71 $263,152 - $453,357
2,092 New
2,092 $441,000
Q3 2023

Nov 14, 2023

BUY
$185.0 - $326.08 $101,750 - $179,344
550 Added 1.44%
38,738 $7.69 Million
Q2 2023

Aug 14, 2023

BUY
$226.52 - $324.64 $5.96 Million - $8.54 Million
26,298 Added 221.18%
38,188 $12.4 Million
Q1 2023

May 15, 2023

SELL
$229.06 - $278.01 $2.65 Million - $3.22 Million
-11,581 Reduced 49.34%
11,890 $2.78 Million
Q4 2022

Feb 14, 2023

SELL
$164.02 - $259.76 $851,919 - $1.35 Million
-5,194 Reduced 18.12%
23,471 $5.91 Million
Q3 2022

Nov 14, 2022

BUY
$170.68 - $226.46 $4.89 Million - $6.49 Million
28,665 New
28,665 $5.08 Million
Q1 2022

May 13, 2022

SELL
$193.94 - $261.91 $1.91 Million - $2.57 Million
-9,825 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$207.57 - $280.17 $828,619 - $1.12 Million
-3,992 Reduced 28.89%
9,825 $2.26 Million
Q3 2021

Nov 12, 2021

BUY
$170.0 - $258.58 $1.79 Million - $2.72 Million
10,500 Added 316.55%
13,817 $3.22 Million
Q2 2021

Aug 13, 2021

SELL
$164.93 - $242.23 $10.4 Million - $15.3 Million
-63,072 Reduced 95.0%
3,317 $641,000
Q1 2021

May 14, 2021

BUY
$182.45 - $249.25 $765,925 - $1.05 Million
4,198 Added 6.75%
66,389 $13.7 Million
Q4 2020

Feb 12, 2021

BUY
$119.35 - $200.46 $7.42 Million - $12.5 Million
62,191 New
62,191 $11.7 Million

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.83B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.